Education
About Us
Working with TipRanks
Follow Us
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Technical Sentiment
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cartesian Therapeutics’s (RNAC) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting Cartesian Therapeutics is a Sell.
Cartesian Therapeutics’s (RNAC) 20-Day exponential moving average is 9.97, while Cartesian Therapeutics’s (RNAC) share price is $9.26, making it a Sell.
Cartesian Therapeutics’s (RNAC) 50-Day exponential moving average is 10.59, while Cartesian Therapeutics’s (RNAC) share price is $9.26, making it a Sell.
Cartesian Therapeutics (RNAC) Pivot Points
Classic
8.67
9.04
9.25
9.62
9.83
10.20
10.41
Fibonacci
9.04
9.26
9.40
9.62
9.84
9.98
10.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Cartesian Therapeutics (RNAC) Moving Averages
MA5
9.73Sell
9.59Sell
MA10
9.69Sell
9.71Sell
MA20
9.87Sell
9.97Sell
MA50
11.01Sell
10.59Sell
MA100
10.83Sell
11.44Sell
MA200
13.74Sell
14.02Sell
Cartesian Therapeutics’s (RNAC) 10-Day exponential moving average is 9.71, while Cartesian Therapeutics’s (RNAC) share price is $9.26, making it a Sell.
Cartesian Therapeutics’s (RNAC) 100-Day exponential moving average is 11.44, while Cartesian Therapeutics’s (RNAC) share price is $9.26, making it a Sell.
Cartesian Therapeutics’s (RNAC) stock price is $9.26 and Cartesian Therapeutics’s (RNAC) 50-day simple moving average is 11.01, creating a Sell signal.
Cartesian Therapeutics’s (RNAC) stock price is $9.26 and Cartesian Therapeutics’s (RNAC) 100-day simple moving average is 10.83, creating a Sell signal.
Cartesian Therapeutics’s (RNAC) stock price is $9.26 and Cartesian Therapeutics’s (RNAC) 200-day simple moving average is 13.74, creating a Sell signal.
Cartesian Therapeutics (RNAC) Technical Indicators
RSI (14)
41.14
Neutral
STOCH (9,6)
35.22
Neutral
STOCHRSI (14)
28.95
Neutral
MACD (12,26)
-0.37
Sell
ADX (14)
16.85
Buy
Williams %R
-89.71
Buy
CCI (14)
-193.30
Buy
ATR (14)
0.63
-
Ultimate Oscillator
43.61
Neutral
ROC
-9.13
Sell
Cartesian Therapeutics’s (RNAC) Relative Strength Index (RSI) is 41.14, creating a Neutral signal.
Cartesian Therapeutics’s (RNAC) Trend Strength Indicator (ADX) is 16.85, creating a Buy signal.
Cartesian Therapeutics’s (RNAC) Commodity Channel Index (CCI) is -193.30, creating a Buy signal.
Cartesian Therapeutics’s (RNAC) Price Rate of Change (ROC) is -9.13, creating a Sell signal.
FAQ
Is RNAC a Buy, Hold, or Sell?
Based on RNAC’s technical indicators, RNAC is a Strong Sell.
What is RNAC’s RSI (14)?
RNAC’s RSI (14) is 41.14, which suggests RNAC is a Neutral.
What is RNAC’s MACD?
RNAC’s MACD is -0.37, which suggests RNAC is a Sell.
What is RNAC’s 5-day moving average?
RNAC’s 5-day moving average is 9.73, which suggests RNAC is a Sell.
What is RNAC’s 20-day moving average?
RNAC 20-day moving average is 9.87, which suggests RNAC is a Sell.
What is RNAC’s 50-day moving average?
RNAC’s 50-day moving average is 11.01, which suggests RNAC is a Sell.
What is RNAC’s 200-day moving average?
RNAC’s 200-day moving average is 13.74, which suggests RNAC is a Sell.
What is RNAC’s Williams % R (14)?
RNAC’s Williams % R (14) is -89.71, which suggests RNAC is a Buy.
What is RNAC’s CCI (14)?
RNAC’s CCI (14) is -193.30, which suggests RNAC is a Buy.